Search

Council on Health Promotion / BY: Peter Thorpe, PGDip October 2018
... are dispatched after 9-1-1 calls are received ( Figure 2 ). How the app works Smart phone users who have downloaded ...
BC Centre for Disease Control / BY: Sergei Likhodii, PhD, DCC, FCACB June 2018
... and identification of compounds with unknown structures.[ 2 ] This powerful system will be available in our laboratory, ...
WorkSafeBC / BY: Olivia Sampson, MD, CCFP, MPH, FRCPC, ABPM July/August 2018
... from HA-MRSA—have increased dramatically in BC.[ 1 , 2 , 3 ] Recent annual surveillance data indicate that CA-MRSA ... 25% of MRSA in BC, with the remainder mostly HA-MRSA.[ 2 ] Therefore, acquisition of MRSA in both occupational and ... to 8%, varying by population, geography, and region.[ 1 , 2 , 4 , 5 ] MRSA is not reportable in BC.[ 6 ] HA-MRSA can be ...
BC Centre for Disease Control / BY: Erin Fraser, DVM, MSc November 2018
... woman with Alzheimer disease who was asymptomatic.[ 2 ] Infection with Baylisascaris occurs when humans ingest ... to people and their pets. Baylisascaris eggs take from 2 to 4 weeks to become infectious and can remain viable in ...
Clinical Articles / BY: F. Michelle Sutter, MD, FRCSC March 2018
... and widely excised tumors, radiation may be omitted.[ 2 ] Consultation with a radiation oncologist is recommended ... in women older than 55 years of age with small (less than 2 cm) tumors and ER-positive, PR-positive, HER2-negative, ... risk are patient age younger than 50, tumor larger than 2 cm, medial primary tumor location,[ 9 ] lymphovascular ...
Beyond Medicine, Interviews July/August 2018
... Dr Cadesky shortly before he became president on 2 June 2018. Beyond Medicine Interviews Advocating for ...
News May 2018
... invited to attend the 2018 annual general meeting (AGM) on 2 June 2018 at the Robert H. Lee Alumni Centre (UBC Campus, ...
BC Centre for Disease Control / BY: Monika Naus, MD, MHSc, FRCPC, FACPM September 2018
... 66.5% against post-herpetic neuralgia unaffected by age.[ 2 ] This vaccine is given as a single dose subcutaneously. In ... and Quillaja saponaria Molina. RZV is given as a 2-dose series intramuscularly, 2 to 6 months apart. The vaccine has performed well in ...
News January/February 2018
... grew by 3.5% in 2016, exceeding the panel’s forecast of 2.7%. There is one remaining opportunity for the Economic ...
Clinical Articles / BY: Kendall Ho, MD, FRCPC December 2017
... positive changes to their overall health and well-being.[ 2 ] These commercially available devices also integrate an ... technologies in clinical settings. Clinical Articles Part 2: Health apps, wearables, and sensors: The advancing ...